China's Innovative Weight-Loss Patch Receives US Clinical Trial Approval

Deep News

Yesterday

SBP GROUP has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the treatment intended for weight management.

The patch, developed by SBP GROUP's core subsidiary Beijing Tide Pharmaceutical, is a GLP-1 receptor agonist delivered via a dissolvable microneedle system. It offers several key advantages, including convenient administration, efficient drug delivery, sterile safety, and ease of storage and transportation, potentially providing a new therapeutic option for individuals requiring long-term weight control.

According to the company's press release, CPX301 is a truly dissolvable microneedle patch. The needle body is constructed from biocompatible materials and manufactured under strict sterile conditions. After application, the microneedles fully dissolve within five minutes, allowing the patch to be removed immediately, making the process both quick and user-friendly.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/news/1151627337"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151627337\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151627337?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151627337","market":"fut","top_or_hot":-1,"title":"China's Innovative Weight-Loss Patch Receives US Clinical Trial Approval","media":"Deep News","content":"<p><b>SBP GROUP</b> has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the treatment intended for weight management.<br><br>The patch, developed by SBP GROUP's core subsidiary Beijing Tide Pharmaceutical, is a GLP-1 receptor agonist delivered via a dissolvable microneedle system. It offers several key advantages, including convenient administration, efficient drug delivery, sterile safety, and ease of storage and transportation, potentially providing a new therapeutic option for individuals requiring long-term weight control.<br><br>According to the company's press release, CPX301 is a truly dissolvable microneedle patch. The needle body is constructed from biocompatible materials and manufactured under strict sterile conditions. After application, the microneedles fully dissolve within five minutes, allowing the patch to be removed immediately, making the process both quick and user-friendly.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's Innovative Weight-Loss Patch Receives US Clinical Trial Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's Innovative Weight-Loss Patch Receives US Clinical Trial Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-08-26 21:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>SBP GROUP</b> has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the treatment intended for weight management.<br><br>The patch, developed by SBP GROUP's core subsidiary Beijing Tide Pharmaceutical, is a GLP-1 receptor agonist delivered via a dissolvable microneedle system. It offers several key advantages, including convenient administration, efficient drug delivery, sterile safety, and ease of storage and transportation, potentially providing a new therapeutic option for individuals requiring long-term weight control.<br><br>According to the company's press release, CPX301 is a truly dissolvable microneedle patch. The needle body is constructed from biocompatible materials and manufactured under strict sterile conditions. After application, the microneedles fully dissolve within five minutes, allowing the patch to be removed immediately, making the process both quick and user-friendly.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BZ08YT58.USD","symbol_name":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","start_time":0,"source_url":"","article_id":"1151627337","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151627337","pubTimestamp":1787749241,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"SBP GROUP has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","BK1191":"制药","01177":"中国生物制药","BK1521":"挪威政府全球养老基金持仓","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","BK1589":"北水核心资产","BK1515":"抗疫概念"},"translate_title":"中国创新减肥贴片获美国临床试验批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"SBP GROUP has announced that its investigational drug CPX301, a dissolvable microneedle patch, has received a green light from the US Food and Drug Administration for clinical trials, with the treatment intended for weight management.The patch, developed by SBP GROUP's core subsidiary Beijing Tide Pharmaceutical, is a GLP-1 receptor agonist delivered via a dissolvable microneedle system. It offers several key advantages, including convenient administration, efficient drug delivery, sterile safety, and ease of storage and transportation, potentially providing a new therapeutic option for individuals requiring long-term weight control.According to the company's press release, CPX301 is a truly dissolvable microneedle patch. The needle body is constructed from biocompatible materials and manufactured under strict sterile conditions. After application, the microneedles fully dissolve within five minutes, allowing the patch to be removed immediately, making the process both quick and user-friendly.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}